First trial results show UK coronavirus vaccine produces a strong immune response, NIHR

A new experimental vaccine for coronavirus causes induces strong immune responses in both parts of the immune system and cause few mild side effects, in promising results from a trial funded and supported by the NIHR. The results of the early trial, published in The Lancet, show that the ChAdOx1 nCoV-19 vaccine generated strong immune responses in both parts of the immune system, activating white blood cells that can attack cells infected with the SARS-CoV-2 virus, and antibodies that find and attack the virus when it ' s circulating in the blood or lymphatic system. The researchers also found that immune responses may be even greater after a second dose. Participants who received the vaccine had detectable neutralising antibodies up to day 56 of the ongoing trial. These responses were strongest after a second booster dose, with 100% of participants ' blood having neutralising activity against the coronavirus. Researchers have suggested that these antibodies are important for protection against the virus.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news